Keywords: |
prednisone; review; doxorubicin; alpha interferon; cytarabine; methotrexate; antineoplastic agent; neoplasms; dacarbazine; granulocyte macrophage colony stimulating factor; cyclophosphamide; vincristine; procarbazine; vinblastine; hodgkin disease; b cell lymphoma; lymphoma, non-hodgkin; lymphoma; bleomycin; human immunodeficiency virus; acquired immunodeficiency syndrome; virus infection; kaposi sarcoma; sarcoma, kaposi; epidemiology; human; priority journal; support, non-u.s. gov't; support, u.s. gov't, p.h.s.
|